| Dr Jessica Laurel Harrison, PSYD | |
|
1825 Academy Dr, Anchorage, AK 99507-5391 | |
| (907) 522-7080 | |
| (907) 522-7088 |
| Full Name | Dr Jessica Laurel Harrison |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 8 Years |
| Location | 1825 Academy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811409592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PY60768994 (Washington) | Secondary |
| 103T00000X | Psychologist | 139675 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christian Health Associates | 7517950686 | 5 |
News Archive
Checking back into the hospital within 30 days of discharge is not only bad news for patients, but also for hospitals, which now face financial penalties for high readmissions. The key to reducing readmissions may be focusing on the whole patient, rather than the specific conditions that caused their hospitalizations, according to a new study by Yale School of Medicine researchers.
Atrial fibrillation is associated with a 5-fold increased risk of stroke. Nearly 3 million Americans are living with AFib. For years, researchers have been looking for ways to reduce the risk of stroke for this patient population.
New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19.
› Verified 1 days ago
| Entity Name | Christian Health Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891911673 PECOS PAC ID: 7517950686 Enrollment ID: O20040405001479 |
News Archive
Checking back into the hospital within 30 days of discharge is not only bad news for patients, but also for hospitals, which now face financial penalties for high readmissions. The key to reducing readmissions may be focusing on the whole patient, rather than the specific conditions that caused their hospitalizations, according to a new study by Yale School of Medicine researchers.
Atrial fibrillation is associated with a 5-fold increased risk of stroke. Nearly 3 million Americans are living with AFib. For years, researchers have been looking for ways to reduce the risk of stroke for this patient population.
New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Laurel Harrison, PSYD 1825 Academy Dr, Anchorage, AK 99507-5391 Ph: (907) 522-7080 | Dr Jessica Laurel Harrison, PSYD 1825 Academy Dr, Anchorage, AK 99507-5391 Ph: (907) 522-7080 |
News Archive
Checking back into the hospital within 30 days of discharge is not only bad news for patients, but also for hospitals, which now face financial penalties for high readmissions. The key to reducing readmissions may be focusing on the whole patient, rather than the specific conditions that caused their hospitalizations, according to a new study by Yale School of Medicine researchers.
Atrial fibrillation is associated with a 5-fold increased risk of stroke. Nearly 3 million Americans are living with AFib. For years, researchers have been looking for ways to reduce the risk of stroke for this patient population.
New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19.
› Verified 1 days ago
James Kyle Timmons, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Potlatch Cir, Anchorage, AK 99503 Phone: 907-947-1862 | |
Raymond Pastorino, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-562-1603 | |
Dr. Sally Schliesmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Redwood Pl, Anchorage, AK 99508 Phone: 907-278-1200 Fax: 907-276-3147 | |
Cale Palmer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3001 C St, Anchorage, AK 99503 Phone: 907-273-4023 | |
Suzette Lewis, PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1825 Academy Dr, Anchorage, AK 99507 Phone: 907-522-7080 Fax: 907-522-7088 | |
Dennis Gall, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4050 Lake Otis Pkwy Ste 105, Anchorage, AK 99508 Phone: 907-433-9628 | |
Kelley Russell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Muldoon Rd, Anchorage, AK 99504 Phone: 907-257-4700 |